By G HossainPosted on November 3, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Sales of assets from Seagen and Biohaven grew in the third quarter, but it wasn’t enough for Pfizer to overcome declines across the Prevnar and COVID franchises. Pfizer flat in Q3 despite 32% growth for new and acquired products Post navigation Eide Bailly grows in TexasNovartis puts $772M BioArctic deal on ice, skates away from brain-delivery alliance
